Guardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa

MUMBAI, India, Dec. 15, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company's flagship liquid biopsy, the Guardant360® test, which oncologists are...

Read more: Guardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision...

More Articles …

  1. Harvard economist Andrei Shleifer joins SKEMA as a visiting professor-PR Newswire APAC
  2. Destination New South Wales - Shoalhaven: Vineyards by the ocean-PR Newswire APAC
  3. Dynabook ANZ unveils new Hyper Light Portégé® X30L-J and Professional Grade Portégé® X40-J Laptop, Featuring 11th Gen Intel® Core™ Processor and Intel® Iris® Xe Graphics Engine
  4. Otto Damsma Joins Bioforum as Vice President of Asia Pacific Operations-PR Newswire APAC
  5. Vestas wins 96 MW order for wind project in Australia-PR Newswire APAC
  6. Ten key ideas in energy-PR Newswire APAC
  7. Dense Air launches 5G in Cascais-PR Newswire APAC
  8. Rodan + Fields Expands Partnership With TerraCycle To Increase Recycling Aimed At Reducing Packaging Waste-PR Newswire APAC
  9. Enel Green Power And Maire Tecnimont Group's NextChem Sign MOU For A Green Hydrogen Production Plant In The United States-PR Newswire APAC
  10. Synechron Acquires Attra-PR Newswire APAC